George Spritzer, CFA is a registered investment advisor at Southland Investments and specializes in managing closed-end funds for individuals.
George uses the following investment strategies:1) Opportunistic Closed-end fund investing: Buy CEFs at larger than normal discounts to NAV and sell them when the discounts narrow. 2) Exploit special situations: tender offers, fund terminations, fund activism, rights offerings etc.
After a decade on Wall Street, I've finally left to start my new venture and focus on some of my other passions. I am also able to spend more time searching for the next great investment opportunity. On top of all that, I'm finally able to blog my ideas so that I can share them with others.
Over the years, I've developed a relative value investing style that lies somewhere between libertarian and contrarian in that I am not afraid to think freely, even if it against the grain at times. During my tenure on Wall Street, I've had experience working with a variety of companies ranging from Fortune 500 companies to small-cap companies across a number of sectors. In addition to advising such companies negotiate mergers and acquisitions or undergo financial restructurings, I also worked with several private equity funds and hedge funds, ranging from TPG and Apollo to Cerberus, Avenue Capital and D.E. Shaw. Such experience working side by side with investors who have a deep rooted understanding of intrinsic value combined with my own personal investing since the mid nineties, I have developed a disciplined approach that I hope others will find beneficial as well.
Brett is an independent trader who specializes in closed-end fund investing, an area he believes is the most inefficient part of the securities markets. He also takes long/short positions in companies he believes to be extremely under/over valued.
Brett is fascinated with the way investors consistently seek short-term, incremental profits at the expense of long-term, extreme losses.
MyPlanIQ.com is the only web application that offers advanced asset allocation strategies customized to a wide range of retirement and taxable investment plans such as 401(k), IRA and brokerage accounts. The unique key advantages of MyPlanIQ.com are
1. Superior investment strategies with high return and low risk
* Asset allocation based on a wide diversified array of assets
* Strategic and Tactical asset allocation that have been well researched, proven and utilized by hedge funds and wealth management
* Superior fund selection.
2. Customization down to specific retirement, variable annuity (VA), variable life insurance (VUL), college savings and brokerage taxable investment plans
* Supporting thousands of 401k, 403b, brokerage ETF/Mutual Fund, IRA, VA, VUL and 529 plans
* Taking redemption, fees and other factors into account for the available investment choices in a plan
* Customized portfolios tailored to available funds in a plan and personal risk profile.
3. An easy to use yet powerful platform
* Online portfolios monitored daily and regular rebalance email notification
* Easy yet powerful tools to allow portfolio construction and study
* A vibrant community to share and discuss investment issues
4. Low cost and flat fee
MyPlanIQ.com enables private investors to achieve institutional investment results and experience with a fraction of cost and efforts.
The clatter of 24/7 investing information has made it harder and harder to focus on the core principles of smart investing. With stock tips rocketing across Twitter and the market’s every nip and pop warranting team coverage on cable TV, it’s not easy to find thoughtful information that will be useful in the long term.
The Portfolioist Blog is a forum for intriguing ideas about long term investing and portfolio building. Articles are written by Geoff Considine and edited by Lauren Tivnan. The blog is made possible by the sponsorship of online brokerage Folio Investing and Folio Institutional. Geoff Considine and Lauren Tivnan are both employees of Folio Investing.
Paolo Gorgo' founded Nortia Research to pursue his passion for equity research. Paolo is an Italy-based investor who mostly analyzes distressed debt and turnaround cases. On Seeking Alpha, he started covering the Telecommunications Infrastructure and Colocation Industry, whose turnaround has been impressive - see Paolo's article: "Equinix's Journey From IPO To The Nasdaq 100 Through Near Bankruptcy".
His commentary has been quoted both by news organizations like Reuters and listed companies like Equinix, Switch and Data, TelX (Digital Realty), etc.
Paolo can be reached at: admin [at] nortiaresearch [dot] com
Ian Wyatt is an active investor, a well-regarded investment expert and an Internet entrepreneur. He is the Chief Investment Strategist at Wyatt Investment Research, and plays a leading role in each of the company’s investment newsletters and trading services.As a well-regarded market expert, Ian has written for Marketwatch, Zacks Investment Research, Seeking Alpha, Yahoo! Finance and The Burlington Free Press. He has been interviewed or quoted in articles in well-known publications including AOL Finance Blogging Stocks, Kiplinger’s Personal Finance Magazine, Barron Magazine, Barrons.com, Forbes.com, The Dick Davis Digest, The Dick Davis Income Digest, The Wall Street Transcript, TheStockAdvisors.com, Money Show Digest, The New Jersey Star Ledger, The Wisconsin State Journal and The Seattle Times.
In 1998, Ian combined two of his passions, stocks and the Internet, with the launch of a free investment web site with expert advice about investing in stocks.
Ian founded Business Financial Publishing and Wyatt Investment Research in 2001, publishing investment newsletters for individual investors. Since then, the company has evolved into an Internet content company publishing e-letters, special reports, newsletters, trading services and financial web sites.
Business Financial Publishing was named #185 on the 2008 Inc. Magazine Inc. 500 list of the fastest growing companies in the United States, achieving a 3-year growth rate of 1,303%. The company currently reaches over one million individual investors weekly through its free e-letters.
His first book, The Small-Cap Investor: Secrets to Winning Big with Small-Cap Stocks, was published by John Wiley & Sons in September 2009. Ian lives in the Green Mountains of Vermont with his wife Carrie.
I am a small-time writer/blogger who dreams big and enjoys researching and writing about biotechs and pharmaceuticals. My work experiences include food safety, water quality, pesticides, food additives, paints, plastics and pharmaceutical precursors. My focus as of late has been researching the treatment options for many cancers and prevention of their recurrence. Additional recent research has been in the stem cell field, an exciting field in its infancy but now becoming a teenager! My ongoing goal for investors is attempting to find under-the-radar or oversold pharmaceuticals or biotechs for investment potential.
Alex B. Gray is the founder and editor of the Scavenger Report newsletter and the ScavengerReport.com website. The Scavenger Report is a research-focused investment newsletter for the independent-minded investor. The ScavengerReport.com website also contains independent research on individual stocks and related articles.
Alex has been an entrepreneurial thinker and private investor for most of his life. Alex is drawing on his over 20 years of experience as a private investor and his very broad experiences as an entrepreneur and corporate executive to uncover opportunities primarily in the equity markets. Prior to founding the Scavenger Report, Alex co-founded a web services company, two e-commerce businesses and an e-commerce software solutions company.
Previous to his entrepreneurial ventures Alex served as Senior Vice President and CIO of American Investment Bank, a former subsidiary of Leucadia National Corporation (NYSE: LUK) and Senior Vice President of Tranex Credit Corp. In addition, Alex has provided independent consulting services to companies in the finance, banking, transportation and real estate management industries. His consulting work was primarily focused on process improvement, cost reduction, risk management and acquisitions.
David Levy serves as Portfolio Manager with Kenjol Capital Management. He is responsible for researching and analyzing investment opportunities, executing trades, and directing IPO participation on behalf of clients. In addition, David is involved in gaining new clients as well as maintaining and strengthening existing client relationships. His responsibilities also include supervising the firm’s custodial relationship with Fidelity Investments. As a Kenjol spokesperson, David has been interviewed and quoted by FoxBusinessLive, CNNMoney.com, Kiplinger’s and Bloomberg Radio on issues as diverse as 401k investing and interpreting daily market action.
Marc is a frequent contributor to Investment U and also The Oxford Club’s Income Specialist and Editor of The Oxford Income Letter. He is the author of the best seller "Get Rich with Dividends".
His investment career started out at the trading desk of Carlin Equities in San Francisco, CA, where he executed dozens of trades each day for his clients.
As a Senior Analyst with Avalon Research Group, his buy recommendation gained 17.8% versus the S&P 500′s 5.9%. While there, Marc started and headed the technical research products division, in addition to his fundamental duties.
Marc also looked at the market with a journalist’s skeptical eye as a columnist for The Street, where he broke several stories on companies in the biotech sector. His contrarian recommendations (including shorts) gained 12.6% annualized versus the S&P 500′s gain of 0.5%.
Along with Oxford Club publications, Marc has appeared on Fox Business, Bloomberg Radio, Yahoo! Finance and been published in the online version of The Wall Street Journal, The Street, U.S News and World Report and was featured on NPR’s “The Story.”
Disclaimer: Money Morning and Stansberry & Associates Investment Research are separate companies, and entirely distinct. Their only common thread is a shared parent company, Agora Inc. Agora Inc. was named in the suit by the SEC and was exonerated by the court, and thus dropped from the case. Stansberry & Associates was found civilly liable for a matter that dealt with one writer’s report on a company. The action was not a criminal matter. The case is still on appeal, and no final decision has been made.
Stephen Simpson, CFA, is a freelance financial writer and investor.
I have worked for both sell-side and buy-side firms (equities and fixed income), with the largest percentage of my working time spent in med-tech. At this point I am now effectively in a "working retirement".
I write because I find that the process helps me take better notes, be more disciplined about modeling, and come up with a more coherent investment view for my portfolio management needs. If I'm writing about a stock, it's generally because I'm interested in it as an investment prospect or I think there's an interesting story to tell.
I don't share my models, so please don't ask.
More of my writings can be found at my blog Kratisto Investing (kratistoinvesting.blogspot.com), or Twitter (@Kratisto_Invest).
Steven Bulwa is an investment analyst with a focus on new developments in science, technology and medicine and the companies poised to benefit. He has contributed to TheStreet.com, Realmoney.com and SeekingAlpha.com, BusinessInsider.com, Mediaite.com and HuffingtonPost.com among others. Steven has actively followed developments in technology for over 20 years, working with a scientific advisory board to validate potential investments. Early in his career, as a musician and recording engineer, Steven recognized the importance of the shift from analog to digital recording. This inspired his first stock investment in a company providing hardware and software solutions to television news providers converting to a digital video environment. The success of this investment inspired Steven to continue to delve into yet-to-be recognized investment opportunities in technology. While writing for thestreet.com in 2006, Steven was one of the first analysts to identify the explosive investment opportunity of 3D Printing. At the time he wrote articles about Stratasys(SSYS) and 3D Systems(DDD). Steven's picks like Nuvasive(NUVA) were also featured on Jim Cramer's Mad Money on CNBC. He has also acted as a consultant to companies looking to acquire new technologies including nanotechnology.
A practical investor, Steven also called the demise of the housing and mortgage markets after listening to one of Ben Bernanke’s early testimonies while simultaneously learning of Bank of America’s efforts to proactively renegotiate troubled home loans. In our capitalist economy, companies only renegotiate out of desperation, trouble was obviously coming!
Technology now evolves so rapidly that there are always great new technology companies with tremendous growth potential to invest in. Big cap tech's strongest growth is past, Steve wants to help you invest in tomorrow’s Apple,Google, or Microsoft.
The Colony Group is an SEC Registered Investment Advisor providing individuals and institutions with personalized investment management services. Our team of experienced CFA charterholders constructs and manages investment portfolios by utilizing a research-intensive, bottom-up fundamental discipline. This approach enables us to identify what we believe are high-quality growth companies trading at reasonable prices.
Brian Katz is the Chief Investment Officer of The Colony Group and is the lead Portfolio Manager for the company’s large-cap equity strategy, which has assets under management of almost $300mm. The Colony Group’s large-cap strategy invests in approximately 30 – 40 securities with market caps generally greater than $5bb. The Portfolio Manager and analysts endeavor to find growth companies with defendable competitive positions that generate strong free cash flow.
I am an independent trader and investor seeking opportunities in energy, deep value, distressed and turnaround plays. I also invest in growth when I see a sustainable long term trend in certain stocks or sectors.
I may occasionally send stock ideas out on Twitter, if exceptional opportunities arise: @rougetrades
The author of Stockerblog worked for over 20 years in the financial services industry as a stockbroker, investment advisor, Vice President of a San Francisco money management firm, mutual fund wholesaler, and market maker on the Pacific Stock Exchange. He has written numerous articles for the Bond and Share Society Journal, Friends of Financial History Magazine, TheStreet.com and many other investment publications. He has also appeared on CNBC and Fox Business News, and is founder of WallStreetNewsNetwork.com.
Visit Stockerblog (http://stockerblog.com/) and WallStreetNewsNetwork.com (http://WallStreetNewsNetwork.com)
The founding members of Chimera Research Group have over 50 years of combined experience in the biotech and pharmaceutical sector. Their experience includes work at Investment Banks, Hedge Funds, Pharmaceutical Companies, top-tier Universities, and the U.S. Food and Drug Administration (FDA). Their published work includes freelance and editorial contributions both print and on-line, clinical and medical research, books and tutorials, as well as contributions to on-line social media. Through these and other activities they were able to collaborate and connect amongst themselves to establish this cadre of like-minded biotech/pharma trading and investing aficionados.
The Team includes:
Chief Scientific Analyst - Jason Chew
Chief Research Analyst - Patrick Crutcher
Chief Medical Analyst - Dr. Tro Kalayjian
CEO & Trading Analyst - Tony Pelz
Research Analyst - Dr. Andrew Goodwin
Research Analyst - Dr. Juan Pedro Rodríguez Serrate
Technical Analyst - Joe Gantoss
Research Analyst - Dr. Steven Murphy
I am an independent equity research analyst and consultant. I focus on finding small-cap biotech stocks where I believe there is favorable risk / reward because of misinformation, lack of information, or a potential fundamental turnaround. I provide detail analysis for investors and investor relations companies. I also provide due diligence and advisory services to companies. Some names I write on I invest in personally and will disclose my position. Names that have hired me to provide due diligence or advisory services I will disclose a business relationship. I previously worked for Zacks Investment Research from 2003 to 2015 as a Senior Biotechnology Analyst. Prior to Zacks, I spent 1999 to 2002 managing money with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology. Prior to joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases, between 1995 and 1998. I also spent a year working at the Fralin Biotechnology Center, and a year working for a cancer researcher while at Virginia Tech. I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University. I hold the Chartered Financial Analyst (CFA) designation.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.
Mark Abssy is the Senior Index & ETF Manager for the International Securities Exchange. In this capacity, Mark is responsible for all phases in the development of innovative tradable products from concept to commercial launch.
Prior to joining ISE, Mark has held various product management positions at Morgan Stanley Investment Management, Fidelity Investments and Loomis Sayles & Company LP and has worked on the institutional client side, managing short-term investments for Genzyme Corporation. Mr. Abssy is a member of the CFA Institute and the New York Society of Security Analysts. He received a BSBA in finance and international business from Northeastern University in Boston, Massachusetts.
A true investing contrarian with more than a decade's experience in the financial markets. I review a variety of sectors with both long and short ideas.
Blog address: http://www.atruecontrarian.com/
The top gold and silver analyst on Seeking Alpha. One of the few that does the hard leg work necessary in this field.
The Gold and Silver Report is in progress and will be ready in a month with a close look at some very interesting names from the junior level all the way up to the majors.
www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas, news and research for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on the TSX, OTC, NASDAQ and global stock exchanges. We have recently expanded our coverage to include Latin American markets.
Ananthan Thangavel is the Managing Director of Lakshmi Capital and Lead Writer for the RealFinance Commodity Analyst Newsletter. He is particularly proud of producing a return 35.01% annualized since inception (through 12/31/11) for his Lakshmi Capital Global Macro ARS clients (www.lakshmi-capital.com/performance).
Mr. Thangavel is frequently interviewed by major media outlets including Forbes and Fox Business. He called the exact top of the silver market in an interview with Bob Lenzner of Forbes (http://www.forbes.com/sites/robertlenzner/2011/04/25/gold-and-silver-due-for-a-10-correction/) and also called gold's collapse in September 2011 (http://video.foxbusiness.com/v/1156274321001/bearish-outlook-for-gold-prices).
Mr. Thangavel authors The Commodity Analyst, a newsletter service that provides weekly in-depth commodity and currency research and trading recommendations as well as daily blog updates to remind investors what to keep any eye out for (www.realfinancenewsletter.com). Ananthan welcomes collaboration and interaction in his Members Forum, a discussion board that allows for direct interaction with Ananthan.
Ananthan Thangavel holds a B.S. in Economics from Northwestern University, and a J.D. from UCLA School of Law.
PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS.